2 sources covering
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
BBC ·
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
Who's covering it
First reported by BBC at · 2 outlets in all
- GuardianFDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
- BBCMakers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnessThe US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.